Cargando…

Updated total IgE reference intervals in Norwegian adults

BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults....

Descripción completa

Detalles Bibliográficos
Autores principales: Vinnes, Erik Wilhelm, Skarbø, Birthe, Wentzel‐Larsen, Tore, Sylte, Marit S., Apelseth, Torunn Oveland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753806/
https://www.ncbi.nlm.nih.gov/pubmed/36705407
http://dx.doi.org/10.1002/iid3.751
_version_ 1784851045615140864
author Vinnes, Erik Wilhelm
Skarbø, Birthe
Wentzel‐Larsen, Tore
Sylte, Marit S.
Apelseth, Torunn Oveland
author_facet Vinnes, Erik Wilhelm
Skarbø, Birthe
Wentzel‐Larsen, Tore
Sylte, Marit S.
Apelseth, Torunn Oveland
author_sort Vinnes, Erik Wilhelm
collection PubMed
description BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults. METHODS: A reference interval study was conducted in accordance to CLSI guidelines. Samples were collected from n = 252 presumably healthy adult participants enrolled through the regional blood donation program. Total IgE measurements were performed on the ImmunoCAP(TM) platform (Thermo Fisher Diagnostics) traceable to the WHO‐reference standard (75/502) for total IgE measurements. RESULTS: An upper 95% total IgE reference limit was estimated to 302 kU/L (90% CI 177–388 kU/L), and the 97.5% percentile was estimated to 391 kU/L (90% CI 344–560 kU/L). No significant differences were found between participants who self‐reported having an allergic disease and participants who did not self‐report having an allergic disease. CONCLUSION: Our results and other recent publications find markedly higher values than adult reference intervals established four decades ago which still remain widely used by clinical laboratories. We therefore recommend total IgE reference intervals should be critically reviewed and updated.
format Online
Article
Text
id pubmed-9753806
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97538062022-12-19 Updated total IgE reference intervals in Norwegian adults Vinnes, Erik Wilhelm Skarbø, Birthe Wentzel‐Larsen, Tore Sylte, Marit S. Apelseth, Torunn Oveland Immun Inflamm Dis Short Reports BACKGROUND: It is important and expected of laboratories to provide updated reference intervals to the clinician. As no recent publications report adult total IgE reference intervals on a Scandinavian population, the aim of our study was therefore to provide an estimate on healthy Norweigian adults. METHODS: A reference interval study was conducted in accordance to CLSI guidelines. Samples were collected from n = 252 presumably healthy adult participants enrolled through the regional blood donation program. Total IgE measurements were performed on the ImmunoCAP(TM) platform (Thermo Fisher Diagnostics) traceable to the WHO‐reference standard (75/502) for total IgE measurements. RESULTS: An upper 95% total IgE reference limit was estimated to 302 kU/L (90% CI 177–388 kU/L), and the 97.5% percentile was estimated to 391 kU/L (90% CI 344–560 kU/L). No significant differences were found between participants who self‐reported having an allergic disease and participants who did not self‐report having an allergic disease. CONCLUSION: Our results and other recent publications find markedly higher values than adult reference intervals established four decades ago which still remain widely used by clinical laboratories. We therefore recommend total IgE reference intervals should be critically reviewed and updated. John Wiley and Sons Inc. 2022-12-15 /pmc/articles/PMC9753806/ /pubmed/36705407 http://dx.doi.org/10.1002/iid3.751 Text en © 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Reports
Vinnes, Erik Wilhelm
Skarbø, Birthe
Wentzel‐Larsen, Tore
Sylte, Marit S.
Apelseth, Torunn Oveland
Updated total IgE reference intervals in Norwegian adults
title Updated total IgE reference intervals in Norwegian adults
title_full Updated total IgE reference intervals in Norwegian adults
title_fullStr Updated total IgE reference intervals in Norwegian adults
title_full_unstemmed Updated total IgE reference intervals in Norwegian adults
title_short Updated total IgE reference intervals in Norwegian adults
title_sort updated total ige reference intervals in norwegian adults
topic Short Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753806/
https://www.ncbi.nlm.nih.gov/pubmed/36705407
http://dx.doi.org/10.1002/iid3.751
work_keys_str_mv AT vinneserikwilhelm updatedtotaligereferenceintervalsinnorwegianadults
AT skarbøbirthe updatedtotaligereferenceintervalsinnorwegianadults
AT wentzellarsentore updatedtotaligereferenceintervalsinnorwegianadults
AT syltemarits updatedtotaligereferenceintervalsinnorwegianadults
AT apelsethtorunnoveland updatedtotaligereferenceintervalsinnorwegianadults